Choi, Jung-Woo <br/><br/>
Clinicopathologic implications of tissue inhibitor of metalloproteinase-1-positive diffuse large B-cell lymphoma.  [electronic resource] 

 -  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc  Jul 2006 
 - 963-73 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0893-3952 
<br/><br/><label>Standard No.: </label>10.1038/modpathol.3800615  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Cluster Analysis<br/>DNA-Binding Proteins--metabolism<br/>Epstein-Barr Virus Infections--immunology<br/>Female<br/>Humans<br/>Interferon Regulatory Factors--metabolism<br/>Lymphoma, B-Cell--immunology<br/>Lymphoma, Large B-Cell, Diffuse--immunology<br/>Male<br/>Middle Aged<br/>Neprilysin--metabolism<br/>Prognosis<br/>Proto-Oncogene Proteins c-bcl-6<br/>Retrospective Studies<br/>Stromal Cells--metabolism<br/>Survival Analysis<br/>Tissue Array Analysis<br/>Tissue Inhibitor of Metalloproteinase-1--metabolism